Journals / Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi / 2011 / Cilt: 21 - Sayı: 2

Mandibula’nın dev hücreli tümörü tedavisinde farmakolojik ve cerrahi tedavi yaklaşımları; 5 yıllık takıp içeren vaka raporu

Pharmacological and surgical interventions for the treatment of giant cell tumor of the mandible; report of a case after 5-year follow-up

Pages
129–133
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we present 5 year follow up findings of a 30-year-old female patient with a giant tumor in her mandible, which was treated with a combination of intralesional corticosteroid injection and nasal calcitonin inhalation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Giant cell lesions are uncommon tumors of the maxillofacial bones.
📊
Key Findings & Data:The tumor may show aggressive or non-aggressive clinical behavior.
💡
Conclusion & Impact:In this article, we present 5 year follow up findings of a 30-year-old female patient with a giant tumor in her mandible, which was treated with a combination of intralesional corticosteroid injection and nasal calcitonin inhalation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Giant cell lesions are uncommon tumors of the maxillofacial bones. The tumor may show aggressive or non-aggressive clinical behavior. Surgery is the main treatment approach. Pharmacological treatment options include calcitonin therapy, intralesional corticosteroid injection and interferon alpha therapy. In this article, we present 5 year follow up findings of a 30-year-old female patient with a giant tumor in her mandible, which was treated with a combination of intralesional corticosteroid injection and nasal calcitonin inhalation.

Özet

Dev hücreli lezyonlar çene-yüz kemiklerinin nadir görülen tümörleridir. Tümör, agresif veya agresif olmayan klinik seyir gösterebilir. Cerrahi, temel tedavi yaklaşımıdır. Farmakolojik tedavi seçenekleri kalsitonin tedavisi, lezyon içi kortikosteroid enjeksiyonu ve interferon alfa tedavisini kapsar. Bu makalede, alt çenesinde dev hücreli tümör mevcut 30 yaşındaki bayan hastaya uygulanan lezyon içi kortikosteroid ve nasal kalsitonin inhalasyonu uygulamalarının 5 yıllık takip bulguları sunulacaktır.

🔖

Cite This Article

YAVUZ, M., ESEN, E., ERDOĞAN, Ö. (2022). Mandibula’nın dev hücreli tümörü tedavisinde farmakolojik ve cerrahi tedavi yaklaşımları; 5 yıllık takıp içeren vaka raporu. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi, Cilt: 21 - Sayı: 2, 129–133. https://ajindex.com/articles/452548

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Stewart JCB. Oral Pathology. Clinical-Pathologic Correlations. 1st Ed. Philadelphia, PA; W.B. Saunders Company; 1993. p. 411
  2. Kratochvil F, Yih W, Zieper M, Meshul C, Gordon M. Comparison of giant cell lesions of cherubism, giant cell granulomas of the jaws and giant cell tumors of long bones using immunohistochemistry and electron microscopy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 492- 493
  3. Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 2002; 60: 1103-1111
  4. Kurtz M, Mesa M, Alberto P. Treatment of a central giant cell lesion of the mandible with intralesional glucocorticosteroids. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91(6):636-637
  5. Terry BC, Jacoway JR: Management of central giant cell lesions: An alternative to surgical therapy. Oral Maxillofac Clin North Am 1994; 6: 579
  6. Harris M. Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 1993; 31: 89-94
  7. Pogrel MA, Regezi JA, Harris ST, Goldring SR. Calcitonin treatment for central giant cell granulomas of the mandible: Report of two cases. J Oral Maxillofac Surg 1999; 57: 848-853
  8. Kaban LB, Mulliken JB, Ezekowitz RA, Ebb D, Smith PS, Folkman J. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alpha-2a. Pediatrics 1999; 103: 1145- 1149
  9. Eisenbud L, Stern M, Rothberg M, Sachs SA. Central giant cell granuloma of the jaws: experiences in management of thirtyseven cases. J Oral Maxillofac Surg 1988; 46: 376-384
  10. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: A clinicopathologic study. J Oral Maxillofac Surg 1986; 44: 708-713
  11. Carlos R, Sedano HO. Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 161-166
  12. Kermer C, Millesi W, Watzke IM. Local injection of corticosteroids for central giant cell granuloma. A case report. Int J Oral Maxillofac Surg 1994; 23: 366-368
  13. Adornato MC, Paticoff KA. Intralesional corticosteroid injection for treatment of central giant-cell granuloma. J Am Dent Assoc 2001; 132: 186-190
  14. Robinson D, Segal M, Nevo Z. Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis. Pathobiology 2002; 70: 333-342. 1